Introduction: A New Chapter for Facet Joint Pain

Facet-mediated spinal pain remains one of the most discussed—and sometimes most misunderstood—areas of interventional pain medicine.

Should every patient with facet arthropathy on MRI receive a facet injection?

Should every patient with a positive medial branch block proceed to radiofrequency ablation?

Are intra-articular facet injections still relevant?

And perhaps most importantly:

These questions have become particularly relevant following publication of the 2026 facet joint guidelines from the American Society of Interventional Pain Physicians (ASIPP).

Published in Pain Physician in June 2026, the updated guideline represents a major evidence review covering diagnosis, medial branch blocks, radiofrequency neurolysis, intra-articular injections, repeat interventions, sedation, antithrombotic therapy and special clinical circumstances. The guideline involved 48 authors and produced 37 recommendations, all receiving 100% acceptance among voting participants.

But there is an important caveat: the authors explicitly state that the guideline is not intended to be an inflexible treatment recommendation or a “standard of care.” Clinical decisions still require individual assessment and shared decision-making.

So what do the 2026 facet joint guidelines actually tell us?

What Are the 2026 Facet Joint Guidelines?

The 2026 facet joint guidelines are an evidence-based clinical framework developed by ASIPP for the diagnosis and management of chronic spinal pain thought to arise from facet joints.

The guideline evaluates interventions across the:

• Cervical spine

• Thoracic spine

• Lumbar spine

It addresses:

1. Clinical diagnosis

2. Diagnostic facet joint nerve blocks

3. Therapeutic medial branch blocks

4. Radiofrequency ablation/neurolysis

5. Intra-articular facet injections

6. Repeat interventions

7. Imaging guidance

8. Sedation

9. Antithrombotic therapy

10. Patients with implanted stimulators or infusion systems

The evidence and recommendation strength vary considerably according to the spinal region and intervention.

That variation is one of the most important messages for practicing pain physicians.

There is no single “facet procedure” with identical evidence for every spinal region.

2026 Facet Joint Guidelines: What Happened to Radiofrequency Ablation?

The short answer is:

Radiofrequency ablation remains an important evidence-supported treatment—but the strength of evidence differs between cervical, thoracic and lumbar procedures.

The 2026 guideline reports:

These distinctions are directly relevant when selecting an intervention for an individual patient.

Is Radiofrequency Ablation Still the “King” of Facet Treatment?

For appropriately selected patients, RFA remains one of the major evidence-supported interventions for facet-mediated spinal pain.

But the phrase “RFA is the gold standard” should be used carefully.

Why?

Because RFA does not treat “facet arthritis” simply because it is visible on an MRI.

It treats pain presumed to be transmitted through the relevant medial branch nerves after an appropriate diagnostic process.

This distinction is fundamental.

The target is the pain generator—not the MRI abnormality

Degenerative changes in the facet joints are common, particularly with increasing age.

A patient can have:

• Facet hypertrophy

• Osteophytes

• Joint-space narrowing

• Facet arthropathy

without having the facet joint as the primary pain generator.

Therefore:

The clinical diagnosis and response to appropriately performed diagnostic blocks remain central to patient selection.

2026 Facet Joint Guidelines and Diagnostic Medial Branch Blocks

One of the most important steps before considering facet denervation is determining whether the suspected facet joint pain is actually mediated through the medial branch nerves.

This is where medial branch blocks (MBBs) become important.

The 2026 guideline considers diagnostic facet joint nerve blocks an important component of evaluating suspected facet-mediated pain. The guideline also emphasizes factors that can influence diagnostic validity, including sedation, opioid use, psychological factors and the presence of pain in multiple spinal regions.

Why can't clinical examination alone diagnose facet pain?

Because physical examination findings are not sufficiently specific to reliably identify the facet joint as the pain generator.

A patient may have:

• Axial low-back pain

• Pain with extension

• Paraspinal tenderness

• Reduced lumbar movement

and still have discogenic, myofascial, sacroiliac or other sources of pain.

Therefore, diagnostic blocks can provide additional information.

How Many Medial Branch Blocks Should Be Performed?

This remains one of the most controversial areas in facet intervention.

There is no universal agreement across all international societies about whether every patient requires:

• No diagnostic block

• A single medial branch block

• Dual comparative medial branch blocks

The answer can depend on the purpose of the diagnostic procedure, the desired specificity, access considerations and the clinical setting.

The 2026 ASIPP framework places significant emphasis on controlled diagnostic interventions and appropriate patient selection before therapeutic facet procedures.

Importantly, other guidelines and payer policies may differ. For example, CMS documentation summarizes differences between societies regarding single versus dual blocks, illustrating that this remains an area of genuine clinical debate rather than a completely settled question.

The important clinical principle

The diagnostic block should not simply answer:

It should also consider:

This is much more informative than relying on a vague statement such as “the injection helped.”

2026 Facet Joint Guidelines: Why Diagnostic Technique Matters

A diagnostic block is itself a diagnostic experiment.

If the procedure is poorly performed, the conclusion may be misleading.

Potential sources of error include:

• Incorrect needle placement

• Inadequate target identification

• Excessive injectate volume

• Spread to adjacent structures

• Systemic analgesic effects

• Opioid administration during the diagnostic procedure

• Heavy sedation

• Poor documentation of baseline pain and function

The 2026 guideline specifically highlights the potential influence of intraoperative opioids on diagnostic validity and recommends avoiding opioids during diagnostic facet joint nerve blocks.

This is an important practical message for trainees:

Where Do Intra-Articular Facet Injections Stand?

This is perhaps one of the most interesting changes to discuss.

Facet joint injections are often used in clinical practice because they are technically straightforward and intuitive:

painful joint → inject the joint → reduce inflammation → reduce pain.

But the evidence for sustained therapeutic benefit is much less convincing than the evidence supporting appropriately selected medial branch interventions and RFA.

The 2026 guideline gives lumbar intra-articular facet joint injections Level IV evidence with a weak recommendation. Cervical intra-articular injections have weak recommendations, with evidence varying between short- and long-term outcomes; thoracic injections have somewhat stronger but still limited evidence.

This does not mean that an intra-articular injection can never help a patient.

It means that the evidence does not support treating it as a universally effective long-term solution for chronic facet-mediated pain.

2026 Facet Joint Guidelines: Cervical vs Thoracic vs Lumbar RFA

One of the most useful aspects of the new guideline is that it does not treat the spine as a single anatomical region.

Lumbar RFA

The evidence for lumbar RFA is classified as Level II with a moderate strength of recommendation.

This continues to support lumbar medial branch RFA in appropriately selected patients with chronic facet-mediated pain.

Cervical RFA

Cervical RFA also has Level II evidence with a moderate recommendation.

However, cervical procedures require particularly careful attention to anatomy, needle positioning and potential complications because of the proximity of important neural and vascular structures.

Thoracic RFA

Thoracic RFA has comparatively less robust evidence, classified as Level III with a weak-to-moderate recommendation.

This is an important reminder:

A more evidence-based statement is:

Does Technique Influence RFA Success?

Absolutely.

The clinical outcome of RFA is influenced not only by who receives the procedure, but also by how the procedure is performed.

The 2026 guideline discusses technical factors including:

• Needle gauge

• Active tip length

• Lesion temperature

• Lesion duration

• Lesion size

• Needle positioning

The guideline gives moderate-to-strong recommendations concerning the influence of lesion parameters, including the use of an 18-gauge needle in the lumbar spine and 20-gauge needles in cervical/thoracic procedures, with specified active-tip considerations.

This has a very practical implication:

RFA is not simply “put the needle near the medial branch and switch on the generator.”

The geometry of the lesion relative to the target nerve matters.

Why Parallel Needle Placement Matters

The medial branch nerves generally course along predictable anatomical structures.

If the active electrode is poorly oriented relative to the nerve, the resulting lesion may not adequately capture the target.

This is why procedural education should include:

• Fluoroscopic anatomy

• Target identification

• Needle trajectory

• Sensory stimulation

• Motor stimulation where appropriate

• Appropriate lesion parameters

• Documentation of technical success

The 2026 guideline's emphasis on lesion size and technical parameters reinforces the idea that procedural technique is part of the treatment—not an afterthought. 

Can RFA Be Repeated?

Yes—when the first procedure produces meaningful and clinically relevant benefit.

The 2026 guideline reports moderate evidence supporting repeat facet interventions, including RFA, with outcomes that can be similar to those achieved after the initial procedure.

But “repeatable” does not mean “automatic.”

A repeat procedure should be based on:

• Previous response

• Duration of benefit

• Functional improvement

• Recurrence of the same clinical pain pattern

• Reassessment of the diagnosis

• Patient preference

• Appropriate technical considerations

A patient who had no meaningful benefit from the first RFA should not simply undergo the same procedure repeatedly without reconsidering the diagnosis and technique.

What About Sedation During Facet Procedures?

This is another area where the 2026 facet joint guidelines provide useful clarification.

Sedation can be helpful for anxious or uncomfortable patients, but diagnostic validity must be protected.

The guideline indicates that mild sedation may be used in appropriate circumstances, while moderate sedation or monitored anesthesia care may be required for some RFA procedures.

However, diagnostic procedures should not be turned into heavily sedated interventions where the patient's pain response becomes difficult to interpret.

A practical principle

The more important the patient's pain response is to the diagnostic decision, the more carefully sedation and analgesic confounders should be controlled.

What About Patients Taking Antithrombotic Drugs?

The 2026 guideline also addresses antithrombotic therapy.

It reports strong evidence with a moderate recommendation that antithrombotic therapy may be continued for facet interventions according to the relevant ASIPP antithrombotic guidance.

However, this should not be interpreted as:

Antithrombotic management remains patient-specific and should consider:

• The specific medication

• Indication for anticoagulation

• Thromboembolic risk

• Renal function

• Procedure-related bleeding risk

• Relevant antithrombotic guidelines

The decision should be individualized rather than based on a blanket rule.

What About Patients With Spinal Cord Stimulators or Intrathecal Pumps?

The 2026 guideline also considers RFA in patients with implanted stimulators and infusion systems.

The evidence and recommendations are more cautious here, with emphasis on appropriate safety precautions and maintaining appropriate distance from implanted systems. The guideline discusses a 15-cm/6-inch distance in relevant circumstances and special precautions for cervical implants.

This is particularly important as the population receiving neuromodulation continues to grow.

Pain physicians increasingly need to understand not only the RFA procedure itself but also how it interacts with implanted technologies.

So, Is RFA Still King?

For appropriately selected facet-mediated pain, RFA remains one of the most important interventional options.

But the 2026 facet joint guidelines give us a more nuanced message than simply:

The modern approach is closer to:

Clinical suspicion → appropriate diagnostic strategy → positive concordant response → carefully selected therapeutic intervention → technically optimized RFA → functional follow-up.

That is a much more defensible evidence-based pathway.

The Biggest Lessons From the 2026 Facet Joint Guidelines

1. Don't treat the MRI

Facet degeneration on imaging does not automatically establish the facet joint as the pain generator.

2. Don't skip the diagnostic reasoning

The decision to perform RFA should follow an appropriate diagnostic process.

3. Don't assume all spinal regions have equal evidence

Lumbar and cervical RFA have stronger evidence than thoracic RFA in the 2026 ASIPP framework.

4. Don't overvalue intra-articular injections

Evidence for therapeutic intra-articular facet injections is weaker, particularly in the lumbar spine.

5. Technique matters

Needle positioning, lesion parameters and technical execution influence the probability of capturing the target nerve.

6. RFA is not a lifetime prescription

Repeat procedures should be based on previous meaningful benefit and clinical reassessment.

7. Guidelines are not substitutes for clinical judgment

The authors themselves state that the guideline is not intended to constitute an inflexible standard of care.

A Practical Algorithm for Facet-Mediated Spinal Pain

Chronic axial spinal pain

↓

Clinical assessment and differential diagnosis

↓

Consider facet-mediated pain when clinical features are appropriate

↓

Exclude or address competing pain generators

↓

Image-guided diagnostic medial branch block(s), according to the selected diagnostic strategy

↓

Assess pain relief + functional improvement + concordance

↓

If diagnostic criteria are satisfied → consider therapeutic intervention

↓

RFA / therapeutic medial branch block / selected alternative

↓

Functional outcome assessment

↓

If substantial benefit followed by recurrence → consider repeat intervention

This algorithm should be adapted to the patient's anatomy, comorbidities, clinical presentation and the applicable local/institutional guidance.

What Does This Mean for Pain Physicians in India and Asia?

The publication of the 2026 facet joint guidelines is particularly relevant to clinicians working in rapidly developing interventional pain practices across Asia.

As access to:

• C-arm fluoroscopy

• Ultrasound

• Radiofrequency generators

• Advanced cannula systems

• Pain fellowships

• Hands-on workshops

continues to increase, procedural availability is no longer the only challenge.

The bigger challenge is appropriate patient selection and evidence-based execution.

A physician may know how to perform a medial branch block technically—but the more important question is:

Likewise, knowing how to position an RF cannula is only part of RFA competency.

A modern pain physician should understand:

Indication → anatomy → diagnosis → technique → lesion parameters → safety → outcome assessment.

This is where structured pain-medicine education becomes particularly important.

Frequently Asked Questions

What are the 2026 facet joint guidelines?

The 2026 facet joint guidelines are updated ASIPP evidence-based recommendations for diagnosing and treating chronic spinal pain associated with facet joints. They cover diagnostic blocks, RFA, therapeutic nerve blocks, intra-articular injections, repeat procedures, sedation, antithrombotic management and special situations.

Do the 2026 facet joint guidelines recommend radiofrequency ablation?

Yes, the guideline supports RFA for appropriately selected patients, with Level II evidence and moderate recommendation strength for cervical and lumbar RFA, while thoracic RFA has Level III evidence with a weak-to-moderate recommendation.

Is lumbar RFA better supported than facet joint injections?

The evidence framework supports lumbar RFA more strongly than lumbar intra-articular facet injections. Lumbar RFA is classified as Level II evidence with a moderate recommendation, whereas lumbar intra-articular injections have Level IV evidence with a weak recommendation.

Do all patients need two medial branch blocks before RFA?

Not all international guidelines agree on the number of diagnostic blocks. The diagnostic strategy remains an area of debate, and clinicians should consider the relevant guideline, diagnostic goals, false-positive concerns and access to care.

Does a positive MRI indicate facet pain?

No. Imaging abnormalities alone do not establish the facet joint as the pain generator. Clinical assessment and, when appropriate, diagnostic blocks are important for confirming the suspected source.

Can radiofrequency ablation be repeated?

Yes. The 2026 guideline reports moderate evidence supporting repeat facet interventions, including RFA, when clinically appropriate and when previous treatment produced meaningful benefit.

Is thoracic RFA as well established as lumbar RFA?

No. The 2026 guideline assigns thoracic RFA a lower evidence level and weaker recommendation than cervical or lumbar RFA.

Should opioids be used during diagnostic medial branch blocks?

The 2026 guideline highlights concerns that intraoperative opioids may affect diagnostic validity and recommends avoiding opioids during diagnostic facet joint nerve blocks.

Can patients on antithrombotic therapy undergo facet interventions?

The 2026 guideline states that antithrombotic therapy may be continued for facet interventions according to applicable ASIPP antithrombotic guidance, but individual risk assessment remains essential.

Are the 2026 facet joint guidelines a mandatory standard of care?

No. The authors explicitly state that the guideline is based on the best available evidence but is not intended to constitute an inflexible treatment recommendation or standard of care.

Conclusion

The most important message from the 2026 facet joint guidelines is not that every patient with facet arthropathy should undergo RFA.

It is that facet intervention should become more selective, more diagnostic and more technically precise.

RFA remains an important evidence-supported treatment for appropriately selected cervical and lumbar facet-mediated pain, while the evidence is less robust for thoracic RFA. Intra-articular facet injections have a considerably weaker evidence base for long-term benefit, particularly in the lumbar spine.

For the practicing pain physician, the future of facet intervention is therefore unlikely to be:

“Injection first, RFA later.”

It is more likely to be:

That is the real direction of evidence-based interventional pain medicine.

References

1. Manchikanti L, Sanapati MR, Albers SL, et al. Updated 2026 Comprehensive Evidence-Based Guidelines for Facet Joint Interventions in the Management of Chronic Spinal Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician. 2026;29(4S):S1-S228. PMID: 42370930.

2. American Society of Interventional Pain Physicians. Updated Facet Joint Intervention Guidelines. ASIPP Guidelines 

3. Guideline Central. 2026 ASIPP Facet Joint Interventions for Chronic Spinal Pain – Key Recommendations. 2026.

4. Manchikanti L, et al. Comprehensive Evidence-Based Guidelines for Facet Joint Interventions in the Management of Chronic Spinal Pain: ASIPP 2020 Guidelines. Pain Physician. 2020;23:S1-S127.

5. Centers for Medicare & Medicaid Services. Facet Joint Interventions for Pain Management. Discussion of diagnostic blocks and differences among guideline recommendations.